Ligand Pharmaceuticals LGND Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's quick ratio?
- Ligand Pharmaceuticals (LGND) reported quick ratio of 21× in Q1 2026.
- How has Ligand Pharmaceuticals's quick ratio changed year-over-year?
- Ligand Pharmaceuticals's quick ratio increased by 317.3% year-over-year, from 5× to 21×.
- What is the long-term trend for Ligand Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's quick ratio has grown at a 35.9% compound annual growth rate (CAGR), from 4.7× to 22×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.